Pittsburgh Post-Gazette from Pittsburgh, Pennsylvania on September 24, 2004 · Page 12
Get access to this page with a Free Trial
Click to view larger version
September 24, 2004

A Publisher Extra Newspaper

Pittsburgh Post-Gazette from Pittsburgh, Pennsylvania · Page 12

Publication:
Location:
Pittsburgh, Pennsylvania
Issue Date:
Friday, September 24, 2004
Page:
Page 12
Cancel
Start Free Trial

Page 12 article text (OCR)

� � � � � � � � � � � � � � � � � � � � � � � � �������������������������� ������������������������ � �������������������������� ���� Forty-four-year-old Michael Siegel is living proof that clinical trials of new medicines can save lives. Working with his doctor, he was enrolled as the first patient in a Phase II trial for an investigational drug to combat leukemia. Three months later the leukemia was in remission and four years later he is still cancer free. Nearly every approach to cancer screening, detection and treatment available today has come from clinical trials. Currently, more than 60 per cent of children with cancer are enrolled in clinical trials, and during the past three decades the cure rate for childhood cancer has risen from less than 10 percent to 75 percent as the result of participation in research. Fewer than 5 percent of adults with cancer are enrolled in clinical trials. Clinical trials are vitally important. That’s why, on October 1st, Bristol-Myers Squibb and our partners in the cancer community are coming together to take that mes- sage out on the road. It’s the Bristol-Myers Squibb Tour of Hope ™ , an incredible week-long ride across America to raise awareness about cancer and the importance of clinical trials.The team of 20 riders is comprised of survivors such as Michael Siegel, caregivers, advocates, healers and researcherswho will ride from Los Angeles to Washington, DC —joined by cancer survivor and six-time Tour de France champion Lance Armstrong, in cities along the way. Now that you know the importance of clinical trials in the fight against cancer, what can you do? The “Promise” is a personal commitment to learn more about this life- threatening disease. By making the Promise, you can honor those who have been touched by cancer and show your support for the importance of cancer research. Following their journey across America, Lance Armstrong and the Tour of Hope Team will deliver your pledge in Washington, DC on October 9th. Make the Promise; follow the tour at www.tourofhope.or g . Clinical trials— the pathway to new medicines Michael Siegel,cancer survivor and 2004 Tour of Hope rider Lance Armstrong,cancer survivor and 2004 Tour of Hope rider There are currently hundreds of new cancer treatments waiting to be studied.Sadly,many people are unaware that clinical trials are an option. Patient participation is vital because medications in de velopment may save lives today and offer hope for the future. JOINTHETOUR. MAKETHE PROMISE. FEEL THE HOPE . 2003 Bristol-Myers Squibb Tour of Hope Team

Get full access with a Free Trial

Start Free Trial

What members have found on this page